SLC5A2 and colonic neoplasm: Research has shown that DAPA has potential anticancer effects on colon cancer cells expressing SGLT2 but not UGT1A9 because cancer HCT116 cells express SGLT2 but not UGT1A9(Okada et al., 2018).